Clinical trial Recruiting at 2 sites Interventional Ages 12 to 65

Exploring how thoughts, feelings, and risks relate to suicidal thoughts and risky actions in teens and adults

Official title: Intra-personal and Interpersonal Psychological Processes Involved in Risk-taking and Suicidal Behaviors Among Vulnerable Adolescents and Adults

Run by Centre Hospitalier Metropole Savoie · NCT06921226 · Data updated 2026-11-12

This study tests a model to understand how perceived burdensomeness, belonging, impulsivity, and suicidal thoughts relate to risky behaviors and suicidality in 12-65 year-olds at risk.

Quick facts

Study typeInterventional
Ages12 Years to 65 Years
SexAll
Enrollment1400 (estimated)
SponsorCentre Hospitalier Metropole Savoie
Academic / other
Locations3 sites (Chambéry, Savoie and 2 other locations)
StatusRecruiting
StartedJune 26, 2025
Main results expectedJune 26, 2027
Study endsJune 26, 2027
Registry record updatedOctober 7, 2026
Trial IDNCT06921226 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Individuals aged 12-65 experiencing at-risk psychological states, including adolescents admitted to pediatric mental health services and adults in community mental health programs.

Probably not a fit

Participants without current suicidal ideation or behavior or those not experiencing the identified risk factors may have limited direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study aims to describe psychological processes that contribute to risk-taking and suicidal behaviors using an Structural Equation Model. It examines how perceived burdensomeness, thwarted belongingness, impulsivity, and suicidal ruminations relate to suicidal ideation and actions in both adults and adolescents. Secondary analyses explore whether risk-taking acts as a mediator across behavioral, self-reported, and cognitive domains, and whether these relationships differ by developmental status. The setting involves clinical and community participants recruited through a hospital center and associated psychosocial programs. The project will address covariates like age group (adult vs. adolescent) and integrates data from diverse sources to understand self-destructive patterns.

Why it matters

Potential benefit: If successful, the findings could improve understanding of risk pathways and help tailor prevention strategies for youths and adults at risk.

How similar studies have gone: Previous work has used structural models to link cognitive and affective factors with suicidality, though this exact combination in adolescents and adults is explored here as a broader, more integrated approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 12-65 years
* Adolescent population considered as at risk in mental health : admitted to the peadiatric department (CHMS).

or - Adult population : user of the Espoir73 association (an association for adults with a mental health problem) or users of SM@RT (CHS, a psycho-social rehabilitation center for adults with a mental illness).

Exclusion Criteria:

\- No suicidal ideation or behaviors (none " Yes " response at the 6 questions of the C-SSRS screen version).

Where it's running

  • CH Métropole Savoie
    Chambéry, Savoie, France
    Recruiting
  • Espoir73
    Francin, France
    Recruiting
  • Centre Hospitalier Spécialisé de la Savoie (CHS)
    Bassens, France
    Not yet recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.